The Center for Translational Health and Medical Biotechnology Researcg (TBIO) has reached a significant milestone by being awarded the ISO 9001 quality certification. This prestigious accreditation recognizes TBIO’s commitment to maintaining the highest standards in quality management systems, ensuring excellence…
In a significant representation of the biotechnology sector, the Deputy Director of TBIO (Center for Translational Health and Medical Biotechnology Research) attended the prestigious CPHI conference held in Barcelona. This event, renowned for its global influence in the pharmaceutical industry,…
On November 30, 2023, the public defense of the Master’s student in Health Biochemistry, Cristiana Vilela, took place. The presented work, titled “From the gut to the brain: is the microbiome a new paradigm for Parkinson’s Disease treatment?” was supervised…
TBIO is pleased to announce its successful attainment of an ERA4HEALTH grant, specifically within the HEALTHEQUITY initiative, in a consortium with the prestigious institutions FIBICO, based in Spain, and NYCU, based in Taiwan. The grant will support the development of the…
A groundbreaking study conducted by Pablo Fernandes, a Master’s student in Health Biochemistry at TBIO, under the guidance of Professor Pedro Coelho, in partnership with BebéVida, has unveiled promising results in the fight against melanoma, one of the most aggressive…
Prof. Daniel Filipe Borges from the Clinical Neurophysiology Technology (ATC) and researcher at the Center for Translational Health and Medical Biotechnology Research (TBIO) of ESS | P.PORTO, as a member of the research team from the Coimbra School of Health…
Join us to discover how new insights are transforming our understanding of science, innovation, and technology! We look forward to welcoming you! Don’t miss this opportunity, please do your registration and submit your Abstract until 30 September!
This is a lead paragraph this is a blog post